MOTS vs. NMRD, UTRS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, BRSH, and CTCXW
Should you be buying Motus GI stock or one of its competitors? The main competitors of Motus GI include Nemaura Medical (NMRD), Minerva Surgical (UTRS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), Bruush Oral Care (BRSH), and Carmell (CTCXW). These companies are all part of the "medical equipment" industry.
Motus GI vs. Its Competitors
Nemaura Medical (NASDAQ:NMRD) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, community ranking, earnings, valuation and risk.
In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.
4.4% of Nemaura Medical shares are held by institutional investors. Comparatively, 20.1% of Motus GI shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by insiders. Comparatively, 0.3% of Motus GI shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Motus GI has higher revenue and earnings than Nemaura Medical. Motus GI is trading at a lower price-to-earnings ratio than Nemaura Medical, indicating that it is currently the more affordable of the two stocks.
Nemaura Medical has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500.
Motus GI received 159 more outperform votes than Nemaura Medical when rated by MarketBeat users. Likewise, 65.73% of users gave Motus GI an outperform vote while only 57.14% of users gave Nemaura Medical an outperform vote.
Summary
Motus GI beats Nemaura Medical on 7 of the 9 factors compared between the two stocks.
Get Motus GI News Delivered to You Automatically
Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Motus GI Competitors List
Related Companies and Tools
This page (NASDAQ:MOTS) was last updated on 6/11/2025 by MarketBeat.com Staff
